Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameQianhai Health
Stock Code00911
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities主要從事採購及批發未經加工處理西洋參業務,包括種植參及野山參,亦銷售經加工處理西洋參及其他產品,客戶主要為二級批發商及零售商,並在香港經營零售門市及店中店專營店。
Listing Date2014-06-27
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港上環永樂街177-183號永德商業中心3樓301-303室
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehangfatg.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 1.98 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueRMB 0.01 / shares
Offer PeriodTo be extracted
Global Offering Shares500,000,000 shares
HK Public Offer Shares (Initial)50,000,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)450,000,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO2,000,000,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 990,000,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 74.1M
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +13004%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約128.6百萬港元
Period-End Cash Balance47.4百萬港元
Listing Expenses~HK$ 63,800,000
Listing Expenses / Funds Raised~6.44%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 HKD
Income Statement
Item 201120122013
Revenue 446,380492,276762,970
Cost of sales -358,224-411,880-583,546
Gross profit 88,15680,396179,424
Other income and gains, net 2,9022,1611,926
Administrative expenses -25,749-19,123-23,616
Net finance costs -17,080-15,768-10,999
Profit before tax 58,05460,770152,939
Income tax expense -13,645-28,428-24,326
Profit attributable to owners 44,40932,342128,613
Balance Sheet
Item 201120122013
Cash and cash equivalents 17,75614,24547,368
Trade and bills receivables 135,18079,57286,942
Inventories 132,419324,822563,718
Total current assets 500,618608,205907,973
Total current liabilities 644,007583,746759,307
Total equity 189,042113,586242,200
Equity attributable to owners 189,042113,586242,200
Interest-bearing borrowings 517,901342,822361,717
Cash Flow Statement
Item 201120122013
Net cash from operating activities 175,2764,78648,081
Net cash from investing activities -154,62187,156-21,900
Net cash from financing activities -6,226-95,9256,865
Net increase in cash 14,429-3,98333,046
Depreciation of PP&E 3,9512,5841,999
Purchase of PP&E -5,827-157-1,287
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 1.5
First Day OpenHK$ 1.48
First Day Change-24.24%
First Day Volume413008000.0
First Day Turnover646165000.0
Use of Proceeds
1、約648,50萬港元(或募集資金凈額的70%) 用作提高本集團的購買能力,及擴大于種植參及野山參批發市場的市場份額。根據現時市場供求,董事估計約648,50萬港元中,約90%將用于購買種植參,及約10%用于購買野山參,全部均將向客戶銷售; 2、約157,50萬港元(或募集資金凈額的17%) 用作償還若干銀行貸款,該等貸款全部均用作營運資金,借貸利率介乎2.22%至6%,并于二零零九年七月或之后提取,且于二零一九年二月之前到期; 3、約2780萬港元(或募集資金凈額的3%) 用作宣傳及推銷本集團旗下的恒發品牌及通過設立店中店專營店擴充零售業務,藉以擴展本集團的零售業務部,及招聘銷售人員管理本集團的店中店專營店; 4、約9270萬港元(或募集資金凈額的10%) 用作一般營運資金及其他一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)
招银国际融资有限公司 CE AVM940
Overall Coordinators (1)
招银国际融资有限公司 CE AVM940
Joint Bookrunners (2)
招银国际融资有限公司 CE AVM940 PING AN SECURITIES (HONG KONG) COMPANY LIMITED CE BMC491
Joint Lead Managers (2)
招银国际融资有限公司 CE AVM940 PING AN SECURITIES (HONG KONG) COMPANY LIMITED CE BMC491

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman楊永仁—
Company Secretary葉德容—
No director data available.

Major Shareholders

Major Shareholders & Holdings楊永仁先生通過Cervera及Athena Power持有約69.45%股份;Cervera持有60%,Athena Power持有9.45%;黃美娟女士(楊永仁先生配偶)持有配偶權益69.45%。
About this page

This page shows Qianhai Health (00911) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect